CVCapsoVision, Inc.
$6.62+41% 1Y
$6.62
$4.4652 weeks$14.42
Latest close: back above its 200-day averageOct 8, 2026what changed →
The financials
CapsoVision, Inc. by the numbers
CapsoVision, Inc. (CV) reported revenue of $3.6M in Q2 2026 (quarter ended Jun 30, 2026), up 9.9% from the same quarter a year earlier. That came with a gross margin of 51% and net loss of $7.5M. For the full year FY2025, revenue was $14M (+15% year on year) and net income −$25M. The next results filing is expected around Nov 12, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $3.6M | $3.3M | +9.9% |
| Gross profit | $1.9M | $1.8M | +3.3% |
| Operating income | −$7.6M | −$4.7M | n/a |
| Net income | −$7.5M | −$4.6M | n/a |
| Diluted EPS | −$0.15 | −$2.02 | n/a |
Medical Devices
The closest names by size in the same industry